Athena's EPS Meets, Net Dips - Analyst Blog
February 16 2012 - 7:15AM
Zacks
Leading vendor of cloud-based
services for physician practices Athenahealth
(ATHN) reported fourth-quarter adjusted (excluding one-time items
other than stock-based compensation expense) earnings per share of
16 cents, matching the Zacks Consensus Estimate and trailing the
year-ago earnings per share of 21 cents.
For fiscal 2011, adjusted earnings
per share of 55 cents missed the Zacks Consensus Estimate of 57
cents and exceeded the year-ago earnings of 37 cents a share.
Net income (as reported) for the
quarter dropped to $5.3 million (or 15 cents per share) from $7.3
million (or 21 cents per share) a year ago, due to higher expenses,
including a 58.2% rise in selling and marketing expense.
Revenues
Revenues for the reported quarter
were up sharply 33% year over year to $92.5 million, beating the
Zacks Consensus Estimate of $92 million. For fiscal 2011, sales
were $324.1 million, up 32%, squeaking past the Zacks Consensus
Estimate of $324 million. The company posted collections of $2
billion in the fourth quarter, up 25%.
As for the two reporting segments,
sales from Business Services were up 33% to $89.3 million while
Implementation and Other revenues rose 41.7% to $3.2 million.
Revenues were mainly bolstered by
continued adoption of the company’s revenue cycle management
(“RCM”) offering athenaCollector and its electronic health record
(“EHR”) service athenaClinicals by physicians. In addition, usage
of the newer products athenaCommunicator and athenaCoordinator
gathered momentum.
Utilization of athenaCollector by
medical providers and physicians grew 20.7% and 20.9%,
respectively, year over year, in the fourth quarter. Furthermore,
the use of athenaClinicals by medical providers (as well as
physicians) almost doubled year over year. The usage of
athenaCommunicator shot up exponentially to 5,830 medical providers
(of whom 4,098 were physicians).
Margins
Adjusted gross margin dropped to
64.2% in the quarter from 66.3% a year ago while adjusted EBITDA
was down to 22.4% from 29.1%. Adjusted operating margin dipped to
17.2% from 24.5% a year ago.
Balance Sheet
Athenahealth exited the quarter
with cash, cash equivalents and available-for-sale investments of
$138.5 million, up 13.7% year over year.
Other
Athenahealth continued, in 2011,
with its effort to create a national health information system. Its
efforts have been successful thus far with the launch of
athenaCoordinator and permission from the regulatory authorities to
build a bilateral system for health information exchange.
Outlook
Athenahealth’s web-based deployment
provides a low-cost scalable service while its flexible rules
engine leads to higher efficiency in claims settlement. The
Software-as-a-Service (SaaS)-based approach allows for a more
flexible delivery mechanism that is expected to help Athenahealth
win deals. The company has traditionally enjoyed high customer
satisfaction rates, which facilitate a larger number of
referrals.
Athenahealth’s unique business
model makes it a strong provider of RCM services (athenaCollector)
to small physician practices. Its EHR product (athenaClinical) is a
key player in ambulatory settings. We believe that sales of
athenaClinical are likely to remain robust, given the opportunity
for physicians to earn incentive payments under the federal
stimulus. In addition, the company will harness its newer products,
namely athenaCommunicator and athenaCoordinator.
The company should benefit from its
extensive athenaCollector client base, as only a minority of its
subscriber base also utilizes athenaClinical. Cross selling
represents a real growth opportunity in the near term. In this
regard, Athenahealth has made rapid strides in capturing the EHR
business of physician practices. However, this segment is shrinking
as hospitals increasingly absorb physician practices.
Athenahealth has geared itself for
the enterprise segment through its strategic alliance with
Microsoft (MSFT) and the acquisition of Proxsys,
both earlier in 2011. The company has recently signed on, and
executed several enterprise-sized deals, which provide it with a
credible and reference-able client base.
Though the federal stimulus will
gradually wind down, the replacement market is growing. Competition
is fierce and larger competitors may benefit from the incumbency
factor. Industry stalwarts, such as Cerner (CERN),
offer long-standing seamless products integrating inpatient and
ambulatory-care systems. Quality Systems (QSII)
and Allscripts Healthcare Solutions (MDRX) are two
other well-known competitors in a crowded field.
We currently have a Neutral
recommendation on Athenahealth. The stock currently retains a Zacks
#2 Rank, which translates into a short-term “Buy”
recommendation.
ATHENAHEALTH IN (ATHN): Free Stock Analysis Report
CERNER CORP (CERN): Free Stock Analysis Report
ALLSCRIPTS HLTH (MDRX): Free Stock Analysis Report
MICROSOFT CORP (MSFT): Free Stock Analysis Report
QUALITY SYS (QSII): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Cerner (NASDAQ:CERN)
Historical Stock Chart
From May 2024 to Jun 2024
Cerner (NASDAQ:CERN)
Historical Stock Chart
From Jun 2023 to Jun 2024